Moderator: Aloysius B. Darwono, MD, PhD
58. rhBMP-2 in short segment thoracolumbar fusion augmented with transforaminal lumbar interbody fusion: does dosage matter?
Dennis G. Crandall, MD1; Andrew S. Chung, DO2; Nina Lara, MD3; Jan Revella, RN1; Michael S. Chang, MD1
1Sonoran Spine Center, Tempe, AZ, US; 2Mayo Clinic, Phoenix, AZ, US; 3Mayo Clinic Phoenix, Phoenix, AZ, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
59. Outcomes following discectomy for lumbar disc herniation in patients with substantial back pain
Simon T. Sørensen, MS1; Leah Y. Carreon, MD, MSc2; Rachid Bech-Azeddine, MD, PhD3; Soren Fruensgaard, MD4; Mikkel Andersen, MD5; Leah Y. Carreon, MD, MSc6
1Center for Spine Surgery & Research, Middelfart Hospital, Middelfart, Denmark; 2Norton Leatherman Spine Center, Louisville, KY, US; 3Bagsvaerd, Denmark; 4Silkeborg Central Hospital, Silkeborg, Denmark; 5Middelfart, Denmark; 6Sygehus Lillebælt - Rygkirurgi Middelfart, Middelfart, Middelfart, Denmark
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
60. Spine patients demystified: what are the predictive factors of poor surgical outcome in patients after elective lumbar spine surgery?
Jose H. Jimenez-Almonte, MD, MS1; Ifeanyi N. Nzegwu, MD2; Boshen Liu, MD3; Zeeshan Akhtar, MA4; Jonathan D. Grabau, BS4; Syed K. Mehdi, MD3; Cale Jacobs, PhD4; R. Carter Cassidy, MD5
1University of Kentucky, Kentucky Clinic, Lexington, KY, US; 2University of Kentucky Department of Orthopedic Surgery and Sports Medicine, Lexington, KY, US; 3University of Kentucky, Lexington, KY, US; 4Lexington, KY, US; 5UK Healthcare/Dept. of Orthopaedics, Lexington, KY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
61. Multi modal analgesia protocol significantly decreased opioid requirements following lumbar spine surgery: results from a feasibility trial
Richard L. Skolasky, ScD1; Alyson Russo, MD2; Allan Gottschalk, MD, PhD1; Brian J. Neuman, MD3
1Johns Hopkins University, Baltimore, MD, US; 2Johns Hopkins Hospital, Baltimore, Maryland, US; 3Baltimore, MD, US
FDA Device/Drug Status: fentanyl (Approved for this indication), acetaminophen (Approved for this indication), valium (Approved for this indication), gabapentin (Approved for this indication), propofol (Approved for this indication), hydromorphone (Approved for this indication), remifentanil (Approved for this indication)
62. Impaction grafting of the pedicle: a biomechanical analysis
Francis H. Shen, MD1; Gerald Hayward, BS2; Jonathan Harris2; Jorge Gonzalez2; Brandon Bucklen, PhD2
1University of Virginia Department of Orthopaedics, Charlottesville, VA, US; 2Globus Medical, Inc., Audubon, PA, US
FDA Device/Drug Status: Pedicle Screws (Approved for this indication), Bone Cement (Approved for this indication)
63. Orthopaedic vs. neurosurgery: understanding 90-day complications and costs in patients undergoing elective 1-to-2 level posterior lumbar fusions by different specialities
Jae Baek, BS1; Azeem T. Malik, MBBS2; Inamullah Khan, MD3; Jeffery Kim, MD2; Elizabeth Yu, MD2; Safdar N. Khan, MD2
1Columbus, OH, US; 2The Ohio State University Wexner Medical Center, Columbus, OH, US; 3Vanderbilt University Medical Center, Nashville, TN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
64. Unfolding the outcomes of surgical treatment of lumbar spinal stenosis: a prospective five- and ten-year follow-up study
Iina Tuomainen, MD1; Janne Pesonen, MD2; Ville Leinonen; Marinko Rade, PhD, MSc3; Maarit Pakarinen, PhD, MD4; Heikki Kröger, MD4; Timo J. Aalto, MD, PhD, DO5
1Department of Physical and Rehabilitation Medicine, Kuopio University Hospital, Kuopio, Finland, KYS, Finland; 2Kuopio University Hospital, Department of Rehabilitation, Kuopio, Finland; 3Kuopio University Hospital, Kuopio, Ita Suomi, Finland; 4Kuopio, Finland; 5Medical Center Ikioma, Mikkeli, Southern Savolax, Finland
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion